ArticleFrontiers in oncology2025

The prognostic impact of surufatinib for the treatment of advanced pancreatic ductal adenocarcinoma: a single center real-world retrospective study.

Yanzhen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.